Go Pro

Kendall Au Analyst Performance

Analyst at Royal Bank Of Canada

Kendall Au is a stock analyst at Royal Bank Of Canada in the healthcare sector, covering 4 publicly traded companies. Over the past year, Kendall Au has issued 5 stock ratings, including buy and hold recommendations. While full access to Kendall Au's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kendall Au's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 0 Years
Buy Recommendations
60.00% 3 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy60.0%3 ratings
Hold40.0%2 ratings
Sell0.0%0 ratings

Out of 5 total stock ratings issued by Kendall Au at Royal Bank Of Canada, the majority (60.0%) have been Buy recommendations, followed by 40.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
50.0% of companies on NYSE
2 companies
NASDAQ
50.0% of companies on NASDAQ
2 companies

Kendall Au, an analyst at Royal Bank Of Canada, currently covers 4 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
4 companies
100.0%

Kendall Au of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
4 companies
100.0%

Kendall Au's Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
8/13/2026Boost Price Target$183.94$190.00Sector Perform
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
8/7/2026Reiterated Rating$19.99$26.00Outperform
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
8/7/2026Boost Price Target$177.53$180.00Sector Perform
Stryker Corporation stock logo
SYK
Stryker
7/31/2026Lower Price Target$320.77$420.00Outperform
DexCom, Inc. stock logo
DXCM
DexCom
7/31/2026Boost Price Target$83.73$90.00Outperform